(Q35958227)

11 August 2017

1 reference

title

Heart failure--the importance of ethnicity (English)

1 reference

11 August 2017

1 reference

4

Gregory Y H Lip

1 reference

11 August 2017

Michael D Sosin

1

1 reference

11 August 2017

Gurbir S Bhatia

series ordinal

2

1 reference

11 August 2017

Russell C Davis

series ordinal

3

1 reference

11 August 2017

publication date

1 December 2004

1 reference

European Journal of Heart Failure

11 August 2017

published in

1 reference

11 August 2017

volume

6

1 reference

11 August 2017

issue

7

1 reference

11 August 2017

page(s)

831-843

1 reference

Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Epidemiologic aspects of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The current cost of heart failure to the National Health Service in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Incidence and aetiology of heart failure; a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial differences in the outcome of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Race, quality of care, and outcomes of elderly patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Survival rates are similar between African American and white patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Ethnic differences in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Black-White Differences in Idiopathic Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Persistence of acute rheumatic fever in the intermountain area of the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Diabetes mellitus and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The impact of ethnicity on type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Multivariate analysis of the relationship of seven variables to blood pressure: Findings of the Chicago Heart Association Detection Project in Industry, 1967–1972

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Ethnic group comparisons of variables associated with ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Is hypertension more severe among U.S. blacks, or is severe hypertension more common?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial differences in cardiac structure and function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Salt sensitivity. Definition, conception, methodology, and long-term issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Precursors of hypertension in black compared to white medical students

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Race and gender influence ambulatory blood pressure patterns of adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Normotensive blacks have heightened sympathetic response to cold pressor test

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial differences in drug response: isoproterenol effects on heart rate in healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Age, race, diagnosis, and sodium effects on the pressor response to infused norepinephrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Cardiovascular and plasma catecholamine response to static exercise in normotensive blacks and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial differences in epinephrine and beta 2-adrenergic receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Reduced dietary potassium reversibly enhances vasopressor response to stress in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Ethnic differences in cyclic AMP accumulation: effect on alpha 2, beta 2, and prostanoid receptor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Blunted blood pressure response to central sympathoinhibition in normotensive blacks: increased importance of nonsympathetic factors in blood pressure maintenance in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Attenuation of isoproterenol-mediated vasodilatation in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The Neurohumoral Axis in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Neurohormones in patients with ischemic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Fundamentals of endothelial function for the clinical cardiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Endothelium-dependent vasodilation is attenuated in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Impaired endothelial-dependent forearm vascular relaxation in black Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effects of black race on forearm resistance vessel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effects of endothelin-1 on circulating adhesion molecules in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial and gender differences in endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Distribution of endothelin receptors in saphenous veins of African Americans: implications of racial differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Hormones and hemodynamics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Renin as a risk factor in essential hypertension: More evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Cardiovascular response in black and white hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Atrial fibrillation and ethnicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Omapatrilat--the story of Overture and Octave

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Bangladeshi patients present with non-classic features of acute myocardial infarction and are treated less aggressively in east London, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Lifetime Risk for Developing Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Sympathoinhibitory Response to Clonidine Is Blunted in Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Epidemiology of heart failure in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Responsiveness to alpha- and beta-adrenergic receptor agonists. Effects of race in borderline hypertensive compared to normotensive men

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Plasma immunoreactive endothelin in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Plasma endothelin levels in hypertension and chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Race, ethnicity, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2003.11.019

10.1016/J.EJHEART.2003.11.019

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference